Journal of Clinical Endocrinology & Metabolism, Vol 81, 3686-3691, Copyright © 1996 by Endocrine Society

ARTICLES

A mechanism for the suppression of estrogen production in polycystic ovary syndrome

SK Agarwal, HL Judd and DA Magoffin
Department of Obstetrics and Gynecology, Cedars-Sinai Research Institute/ University of California, School of Medicine, Los Angeles 90048, USA.

In polycystic ovary syndrome (PCOS), follicle development arrests in the early antral stage when aromatase expression in the granulosa cells (GC) would normally occur. Despite high intrafollicular concentrations of androstenedione and bioactive FSH, in vivo estrogen biosynthesis remains low. When GC from PCOS follicles are stimulated with FSH in vitro, a marked stimulation of estrogen production occurs, suggesting that PCOS follicles contain an endogenous inhibitor of estrogen production. To test this hypothesis, GC from hyperstimulated women were cultured with increasing concentrations of follicular fluid (FF) from PCOS and normally cycling control women in the presence of androstenedione (10(-5) mol/L). FF from control women caused a small decrease (20%) in estradiol production. PCOS FF caused a dose-related inhibition of estradiol production (60%), indicating that there was significantly more inhibitory activity in PCOS FF. To determine whether abnormal androgen metabolism could play a role in inhibiting estradiol production in PCOS, we measured 5 alpha-androstane-3, 17-dione, a competitive inhibitor of aromatase activity, in serum and FF of control and PCOS women. 5 alpha-Androstane-3, 17-dione levels in serum were significantly elevated in PCOS. 5 alpha-Androstane-3, 17-dione levels were 1000-fold higher in PCOS FF than serum. Moreover, FF levels were markedly higher in PCOS follicles (P < 0.0001) than in normal dominant and cohort follicles. Dose-response studies revealed that the concentration of 5 alpha-androstane-3, 17-dione present in FF form normal dominant follicles (79.4 +/- 14.6 nmol/L) had little effect on estradiol production. In contrast, 5 alpha-androstane-3, 17-dione levels in PCOS FF (581.6 +/- 62.9 nmol/L) inhibited estradiol production by 75%. These data support the hypothesis that PCOS FF contains one or more endogenous inhibitors of aromatase activity and suggest that abnormally high 5 alpha-androstane-3, 17-dione levels in PCOS FF may be an important inhibitor of estradiol production.

This article has been cited by other articles:

				J. R. Wood, D. A. Dumesic, D. H. Abbott, and J. F. Strauss III Molecular Abnormalities in Oocytes from Women with Polycystic Ovary Syndrome Revealed by Microarray Analysis J. Clin. Endocrinol. Metab., February 1, 2007; 92(2): 705 - 713. [Abstract] [Full Text] [PDF]

				S. C. Foong, D. H. Abbott, M. A. Zschunke, T. G. Lesnick, J. L. Phy, and D. A. Dumesic Follicle Luteinization in Hyperandrogenic Follicles of Polycystic Ovary Syndrome Patients Undergoing Gonadotropin Therapy for in Vitro Fertilization J. Clin. Endocrinol. Metab., June 1, 2006; 91(6): 2327 - 2333. [Abstract] [Full Text] [PDF]

				R. F. Casper and M. F. M. Mitwally Aromatase Inhibitors for Ovulation Induction J. Clin. Endocrinol. Metab., March 1, 2006; 91(3): 760 - 771. [Abstract] [Full Text] [PDF]

				J. C. Marshall Obesity in Adolescent Girls: Is Excess Androgen the Real Bad Actor? J. Clin. Endocrinol. Metab., February 1, 2006; 91(2): 393 - 395. [Full Text] [PDF]

				J. A Visser, F. H de Jong, J. S E Laven, and A. P N Themmen Anti-Mullerian hormone: a new marker for ovarian function Reproduction, January 1, 2006; 131(1): 1 - 9. [Abstract] [Full Text] [PDF]

				T. J Wilkin and L. D Voss Metabolic syndrome: maladaptation to a modern world J R Soc Med, November 1, 2004; 97(11): 511 - 520. [Full Text] [PDF]

				A. J. Zeleznik, L. Little-Ihrig, and S. Ramasawamy Administration of Dihydrotestosterone to Rhesus Monkeys Inhibits Gonadotropin-Stimulated Ovarian Steroidogenesis J. Clin. Endocrinol. Metab., February 1, 2004; 89(2): 860 - 866. [Abstract] [Full Text] [PDF]

				J. S. E. Laven, A. G. M. G. J. Mulders, J. A. Visser, A. P. Themmen, F. H. de Jong, and B. C. J. M. Fauser Anti-Mullerian Hormone Serum Concentrations in Normoovulatory and Anovulatory Women of Reproductive Age J. Clin. Endocrinol. Metab., January 1, 2004; 89(1): 318 - 323. [Abstract] [Full Text] [PDF]

				D. A. Dumesic, R. D. Schramm, I. M. Bird, E. Peterson, A. M. Paprocki, R. Zhou, and D. H. Abbott Reduced Intrafollicular Androstenedione and Estradiol Levels in Early-Treated Prenatally Androgenized Female Rhesus Monkeys Receiving Follicle-Stimulating Hormone Therapy for In Vitro Fertilization Biol Reprod, October 1, 2003; 69(4): 1213 - 1219. [Abstract] [Full Text] [PDF]

				S. Greisen, T. Ledet, and P. Ovesen Effects of androstenedione, insulin and luteinizing hormone on steroidogenesis in human granulosa luteal cells Hum. Reprod., October 1, 2001; 16(10): 2061 - 2065. [Abstract] [Full Text] [PDF]

				N. Kikuchi, K. Andoh, Y. Abe, K. Yamada, H. Mizunuma, and Y. Ibuki Inhibitory Action of Leptin on Early Follicular Growth Differs in Immature and Adult Female Mice Biol Reprod, July 1, 2001; 65(1): 66 - 71. [Abstract] [Full Text] [PDF]

				M.P. Teissier, H. Chable, S. Paulhac, and Y. Aubard Comparison of follicle steroidogenesis from normal and polycystic ovaries in women undergoing IVF: relationship between steroid concentrations, follicle size, oocyte quality and fecundability Hum. Reprod., December 1, 2000; 15(12): 2471 - 2477. [Abstract] [Full Text] [PDF]

				M.P. Teissier, H. Chable, S. Paulhac, and Y. Aubard Recombinant human follicle stimulating hormone versus human menopausal gonadotrophin induction: effects in mature follicle endocrinology Hum. Reprod., September 1, 1999; 14(9): 2236 - 2241. [Abstract] [Full Text] [PDF]

				A. J. Jakimiuk, S. R. Weitsman, and D. A. Magoffin 5{alpha}-Reductase Activity in Women with Polycystic Ovary Syndrome J. Clin. Endocrinol. Metab., July 1, 1999; 84(7): 2414 - 2418. [Abstract] [Full Text]

				D. S. Willis, H. Watson, H. D. Mason, R. Galea, M. Brincat, and S. Franks Premature Response to Luteinizing Hormone of Granulosa Cells from Anovulatory Women with Polycystic Ovary Syndrome: Relevance to Mechanism of Anovulation J. Clin. Endocrinol. Metab., November 1, 1998; 83(11): 3984 - 3991. [Abstract] [Full Text]